Honda makes a big play for US drivers
The company is growing here, but at a steep price. Spending on discounts and other incentives hit $2,206 per vehicle last year.
Like all automakers, Honda's facing a recession in Europe and a slowdown in China. (For a closer look at the company's earnings numbers, click here.) The U.S. was a bright spot, as rising sales of the Accord sedan, the CR-V sport utility vehicle and higher-end Acura RDX pushed revenue in North America up 26% to $13.67 billion in the fiscal third quarter. Its U.S. market share grew to 9.8% in 2012 from 9% in 2011, according to the Wall Street Journal.
American Honda said its sales last year rose 24% to 1.42 million vehicles in the U.S., the fourth highest total in its history. December sales were the company's second-best ever. The automaker hopes to do even better in 2013. About 40% of the company's worldwide sales come from the United States.
Honda's growth, however, came at a steep price. The company's spending on incentives climbed to $2,206 per vehicle in 2012, according to data from Autodata cited by the Journal. Executives are prepared to offer even more deals to boost sales in 2013.
Shareholders are always leery of companies offering more discounts to move product, and Honda is no exception. U.S. shares of the automaker were trading down in early trading. They have jumped nearly 11% over the past year.
Automakers often brag in their ads that they are offering the "deal of a lifetime." In Honda's case, it may not be hyperbole.
Check out this video review of the Honda 2013 Civic EX, which is in a deeply competitive market right now.
--Jonathan Berr will drive his 2003 Honda Element until the bolts fall off. He doesn't own shares of the listed stocks.
More on moneyNOW
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The S&P 500 continues hovering near its high, which is a bit surprising considering several noteworthy areas like biotechnology, chipmakers, transport stocks, and retailers underperform.
The biotech space is on its low with the iShares Nasdaq Biotechnology ETF (IBB 264.30, -2.55) down 1.0%. Elsewhere, the PHLX Semiconductor Index trades flat even as the technology sector outperforms with a gain of 0.5%.
Moving on, transport stocks have pressured the Dow ... More
More Market News
But the fact that the guilty bankers are still free and not even on the run is the real outrage here, a travesty that should never be forgotten.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'